FMR LLC increased its stake in Danaher Co. (NYSE:DHR - Free Report) by 15.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,617,424 shares of the conglomerate's stock after buying an additional 3,217,631 shares during the quarter. FMR LLC owned approximately 3.27% of Danaher worth $6,566,116,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of DHR. Legal & General Group Plc lifted its position in shares of Danaher by 2.4% during the 2nd quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate's stock valued at $1,490,112,000 after acquiring an additional 139,989 shares during the period. Fisher Asset Management LLC grew its stake in Danaher by 2.6% during the third quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate's stock worth $1,265,725,000 after buying an additional 116,299 shares in the last quarter. Massachusetts Financial Services Co. MA increased its holdings in Danaher by 17.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock valued at $996,141,000 after buying an additional 535,254 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of Danaher by 2.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,398,649 shares of the conglomerate's stock worth $849,195,000 after acquiring an additional 85,081 shares during the period. Finally, Swedbank AB acquired a new stake in shares of Danaher during the 1st quarter worth approximately $676,545,000. Institutional investors own 79.05% of the company's stock.
Wall Street Analyst Weigh In
DHR has been the subject of several recent analyst reports. Robert W. Baird cut their target price on Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research note on Wednesday, October 23rd. Evercore ISI boosted their target price on Danaher from $275.00 to $278.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 1st. TD Cowen raised their price target on shares of Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. Wolfe Research upgraded shares of Danaher from a "peer perform" rating to an "outperform" rating and set a $285.00 price target for the company in a report on Thursday, October 31st. Finally, Royal Bank of Canada cut their price objective on Danaher from $333.00 to $311.00 and set an "outperform" rating on the stock in a report on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $287.16.
View Our Latest Stock Analysis on Danaher
Danaher Trading Down 0.5 %
DHR stock traded down $1.10 during mid-day trading on Tuesday, reaching $236.58. The company's stock had a trading volume of 1,697,380 shares, compared to its average volume of 2,763,434. The company has a market cap of $170.88 billion, a price-to-earnings ratio of 45.35, a price-to-earnings-growth ratio of 4.34 and a beta of 0.85. Danaher Co. has a 12 month low of $215.68 and a 12 month high of $281.70. The business's 50 day moving average price is $257.38 and its 200 day moving average price is $259.93. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.
Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts' consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business's quarterly revenue was up 3.1% on a year-over-year basis. During the same period last year, the company posted $2.02 earnings per share. On average, equities research analysts predict that Danaher Co. will post 7.5 EPS for the current year.
Danaher Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date was Friday, September 27th. Danaher's dividend payout ratio (DPR) is 20.61%.
Danaher Profile
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.